Unlocking Healthcare Opportunities in Indonesia: Regulatory Insights and Strategies   Background Indonesia, as the largest economy in Southeast Asia, has seen significant growth and development in its pharmaceutical and medical device sectors. With a population of over 270 million, the demand for healthcare products and services continues to rise, making the country a strategic market for local and international companies. The Indonesian government has been actively working to improve the regulatory environment, enhance healthcare infrastructure, and attract foreign investments to

Hampir semua wanita di Indonesia menggunakan kosmetik untuk membantu menunjang penampilannya. Sehingga dibutuhkan pengawasan dari badan berwenang BPOM (Badan Pengawas Obat dan Makanan) untuk dapat memastikan bahwa setiap produk kosmetik yang digunakan dan beredar di pasaran telah memenuhi standar sesuai, seperti berkhasiat dan aman untuk digunakan. Pengawasan dari BPOM terhadap produk kosmetik ini berfungsi untuk melindungi konsumen dari bahaya produk kosmetik yang over claim terhadap bahan-bahannya, namun tidak sesuai dengan apa yang dipromosikan. Secara umum, ada tiga rangkaian proses pengawasan

Navigating Pharmaceutical Regulations in the Philippines: Trends, Challenges, and Registration Process   The medical device market in the Philippines is undergoing significant changes driven by regulatory updates, market demands, and the ongoing impact of the COVID-19 pandemic. This article delves into the current landscape, key drivers, and future outlook of the medical device industry in the Philippines, drawing insights from the 19th Government Affairs and Regulatory Affairs (GARA) conference held in 2023.   Pharmaceutical Landscape in the Philippines In 2024,